Guardant Health Director Steve Krognes Sells ~$1.17M in Stock

Transaction Summary

On September 16, 2026, Guardant Health, Inc. (GH) Director Steve E. Krognes executed open-market sales of 6,674 shares of common stock at a volume-weighted average price of $175.74, yielding gross proceeds of approximately $1,172,885.70.

The sales were reported across four tranches at prices ranging between $173.98 and $177.945:

• 1,103 shares at a weighted average price of $174.4623
• 3,300 shares at a weighted average price of $175.4206
• 1,300 shares at a weighted average price of $176.3354
• 971 shares at a weighted average price of $177.4766

Following these dispositions, Krognes's direct holdings decreased from 14,580 shares to 7,906 shares.

Insider Background & Holding Impact

Steve E. Krognes serves as a member of Guardant Health's Board of Directors. The sale of 6,674 shares represents a significant 45.78% reduction of his directly held equity position in the issuer. The filing does not indicate that the trades were conducted under a Rule 10b5-1 trading plan.

Market Significance

This transaction is categorized as Medium Significance. While board members routinely monetize equity positions, shedding nearly half of a direct ownership position in open-market transactions without an indicated 10b5-1 plan may draw attention from market participants, despite the transaction dollar value being moderate relative to Guardant Health's market capitalization.